UB Paderborn / Katalog / Suche / in CDI

Enfermedad de Parkinson: Nuevas posibilidades con lisurida

P. A. Fischer, Y B. Frieling

2020

Volltextzugriff (PDF)

Enfermedad de Parkinson: Nuevas posibilidades con lisurida

2020

Volltextzugriff (PDF)

The effect of l-3,4-dihydroxyphenylalanine (=DOPA) on akinesia in parkinsonism

Parkinsonism & related disorders, 1998-08, Vol.4 (2), p.59-60

1998

Volltextzugriff (PDF)

The effect of l-3,4-dihydroxyphenylalanine (= DOPA) on akinesia in parkinsonism. 1961

Wiener Klinische Wochenschrift, 2001-11, Vol.113 (22), p.851-854

2001

Volltextzugriff (PDF)

Nicotinamide adenine dinucleotide (NADH)--a new therapeutic approach to Parkinson's disease. Comparison of oral and parenteral application

Acta neurologica Scandinavica, 1993-01, Vol.146 (S146), p.32-35

1993

Volltextzugriff (PDF)

Increased life expectancy resulting from addition of L-deprenyl to madopar® treatment in Parkinson's disease: a longterm study

Journal of Neural Transmission, 1985-06, Vol.64 (2), p.113-127

1985

Volltextzugriff (PDF)

Stimulation of endogenous L-dopa biosynthesis - a new principle for the therapy of Parkinson's disease. The clinical effect of nicotinamide adenine dinucleotide (NADH) and nicotinamide adenine dinucleotidephosphate (NADPH)

Acta neurologica Scandinavica, 1989-11, Vol.80 (s126), p.183-187

1989

Volltextzugriff (PDF)

Deprenyl (selegiline) in the treatment of Parkinson's disease

Acta neurologica Scandinavica, 1983-01, Vol.68 (s95), p.103-106

BIRKMAYER, W.

1983

Volltextzugriff (PDF)

Small-scale plasma-density depletions in Arecibo high-frequency modification experiments

Physical review letters, 1986-08, Vol.57 (8), p.1008-1011

1986

Volltextzugriff (PDF)

Strategy and tactic of modern Parkinson therapy

Acta neurologica Scandinavica, 1989-11, Vol.80 (s126), p.63-66

1989

Volltextzugriff (PDF)

Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlations

Journal of the neurological sciences, 1973-12, Vol.20 (4), p.415-455

1973

Volltextzugriff (PDF)

Dopamine action and disorders of neurotransmitter balance

Gerontology (Basel), 1987, Vol.33 (3-4), p.168

1987

Volltextzugriff (PDF)

Walther Birkmayer

Therapie der Gegenwart, 1969-09, Vol.108 (9), p.1352 passim

Birkmayer, W

1969

Volltextzugriff (PDF)

Nicotinamidadenindinucleotide (NADH): the new approach in the therapy of Parkinson's disease

Annals of clinical and laboratory science, 1989, Vol.19 (1), p.38-43

1989

Volltextzugriff (PDF)

Long term treatment with L-deprenyl

Journal of Neural Transmission, 1978-09, Vol.43 (3-4), p.239-244

Birkmayer, W

1978

Volltextzugriff (PDF)

Measurement of cerebral blood circulation with radioangiography

Wiener Klinische Wochenschrift, 1960-01, Vol.72, p.27-28

BIRKMAYER, W

1960

Volltextzugriff (PDF)

Enfermedad de Parkinson: Nuevas Posibilidades con Lisurida

1, 1991

Volltextzugriff (PDF)

Iron, a new aid in the treatment of Parkinson patients

Journal of Neural Transmission, 1986-09, Vol.67 (3-4), p.287-292

1986

Volltextzugriff (PDF)

Milestones in the development of modern Parkinson therapy

Journal of neural transmission. Supplementum, 1987, Vol.25, p.1

Birkmayer, W

1987

Volltextzugriff (PDF)

The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia

Wiener Klinische Wochenschrift, 1961-11, Vol.73, p.787-788

1961

Volltextzugriff (PDF)

DL-3,4-threo-DOPS in Parkinson's disease: effects on orthostatic hypotension and dizziness

Journal of Neural Transmission, 1983-09, Vol.58 (3-4), p.305-313

1983

Volltextzugriff (PDF)

Clinical experiences with clobazam [proceedings]

British journal of clinical pharmacology, 1979-01, Vol.7 (S1), p.121S-122S

Birkmayer, W

1979

Volltextzugriff (PDF)

The potentiation of the anti akinetic effect after L-dopa treatment by an inhibitor of MAO-B, Deprenil

Journal of Neural Transmission, 1975-09, Vol.36 (3-4), p.303-326

1975

Volltextzugriff (PDF)

Observations of small-scale plasma density depletions in Arecibo HF Heating Experiments

Journal of Geophysical Research, 1987-05, Vol.92 (A5), p.4629-4637

1987

Volltextzugriff (PDF)

IMPLICATIONS OF COMBINED TREATMENT WITH 'MADOPAR' AND L-DEPRENIL IN PARKINSON'S DISEASE: A Long-term Study

The Lancet (British edition), 1977-02, Vol.309 (8009), p.439-443

1977

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Enfermedad de Parkinson: Nuevas posibilidades con lisurida

Enfermedad de Parkinson: Nuevas posibilidades con lisurida

The effect of l-3,4-dihydroxyphenylalanine (=DOPA) on akinesia in parkinsonism

The effect of l-3,4-dihydroxyphenylalanine (= DOPA) on akinesia in parkinsonism. 1961

Nicotinamide adenine dinucleotide (NADH)--a new therapeutic approach to Parkinson's disease. Comparison of oral and parenteral application

Increased life expectancy resulting from addition of L-deprenyl to madopar® treatment in Parkinson's disease: a longterm study

Stimulation of endogenous L-dopa biosynthesis - a new principle for the therapy of Parkinson's disease. The clinical effect of nicotinamide adenine dinucleotide (NADH) and nicotinamide adenine dinucleotidephosphate (NADPH)

Deprenyl (selegiline) in the treatment of Parkinson's disease

Small-scale plasma-density depletions in Arecibo high-frequency modification experiments

Strategy and tactic of modern Parkinson therapy

Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlations

Dopamine action and disorders of neurotransmitter balance

Walther Birkmayer

Nicotinamidadenindinucleotide (NADH): the new approach in the therapy of Parkinson's disease

Long term treatment with L-deprenyl

Measurement of cerebral blood circulation with radioangiography

Enfermedad de Parkinson: Nuevas Posibilidades con Lisurida

Iron, a new aid in the treatment of Parkinson patients

Milestones in the development of modern Parkinson therapy

The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia

DL-3,4-threo-DOPS in Parkinson's disease: effects on orthostatic hypotension and dizziness

Clinical experiences with clobazam [proceedings]

The potentiation of the anti akinetic effect after L-dopa treatment by an inhibitor of MAO-B, Deprenil

Observations of small-scale plasma density depletions in Arecibo HF Heating Experiments

IMPLICATIONS OF COMBINED TREATMENT WITH 'MADOPAR' AND L-DEPRENIL IN PARKINSON'S DISEASE: A Long-term Study

Suchergebnisse filtern